Providence Press Room

Welcome to the Providence Press Room. Here, you can find information about Providence, media contacts, press releases and statements, and other information about the family of organizations.

Contact Us

If you are a member of the news media, please reach out with media requests here.

Latest National Press Releases

Providence reports Q3 2024 results
11/26/2024
Providence announced results for the three months ended September 30, 2024. The not-for-profit health system continued to improve performance while serving more people in need.
Two clinical trials for solid tumor cancers take different approaches to stop growth
11/22/2024
Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.
Providence names Darryl A. Elmouchi, M.D., next chief operating officer
11/19/2024
Providence selects Darryl A. Elmouchi, M.D., MBA, as its new chief operating officer, effective Jan. 2.
Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
Providence's Health Connect Partners achieves historic milestones in value-based care delivery with $137 million in savings to Medicare
11/12/2024
Health Connect Partners (HCP), Providence's Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO), generated more than $137 million in savings to CMS in 2023.
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
10/30/2024
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
New studies test immunotherapy to boost breast cancer treatment and prevent return
10/30/2024
Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.
Providence and Compassus announce joint venture for home-based care services
10/22/2024
Providence and Compassus have announced an agreement to form a joint venture partnership for home health, hospice, community-based palliative care, and private duty caregiving services.